Rivastigmine Oral Market Report

Global and Region Rivastigmine Oral Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：214
  • REPORT CODE：GMM980358
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.

    The report details the trend, potential and market size of Rivastigmine Oral market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Rivastigmine Oralmarket, defines the market attractiveness level of Rivastigmine Oral market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Rivastigmine Oral industry, describes the types of Rivastigmine Oral market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rivastigmine Oral market and the development prospects and opportunities of Rivastigmine Oral industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rivastigmine Oral market in Chapter 13.

    By Player:

    • APOTEX

    • Novartis

    • Teva

    • Alembic Pharmaceuticals

    • Cadila Pharmaceuticals

    • Ajanta Pharma

    • Dr Reddy's Laboratories

    • Orchid Healthcare

    • Aurobindo Pharma

    • Mylan Pharmaceuticals

    • Sun Pharmaceutical

    • MACLEODS

    By Type:

    • 15 mg Capsules

    • 3 mg Capsules

    • 45 mg Capsules

    • 6 mg Capsules

    • 2mg/ml Oral solution

    By End-User:

    • Alzheimer's disease

    • Parkinson's

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Rivastigmine Oral Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Rivastigmine Oral Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Rivastigmine Oral Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Rivastigmine Oral Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Rivastigmine Oral Market Analysis and Outlook to 2022

    • 7.1 Global Rivastigmine Oral Consumption (2017-2022)

    • 7.2 United States Rivastigmine Oral Consumption (2017-2022)

    • 7.3 Europe Rivastigmine Oral Consumption (2017-2022)

    • 7.4 China Rivastigmine Oral Consumption (2017-2022)

    • 7.5 Japan Rivastigmine Oral Consumption (2017-2022)

    • 7.6 India Rivastigmine Oral Consumption (2017-2022)

    • 7.7 South Korea Rivastigmine Oral Consumption (2017-2022)

    8 Region and Country-wise Rivastigmine Oral Market Analysis and Outlook to 2028

    • 8.1 Global Rivastigmine Oral Consumption Forecast (2022-2028)

    • 8.2 United States Rivastigmine Oral Consumption Forecast (2022-2028)

    • 8.3 Europe Rivastigmine Oral Consumption Forecast (2022-2028)

    • 8.4 China Rivastigmine Oral Consumption Forecast (2022-2028)

    • 8.5 Japan Rivastigmine Oral Consumption Forecast (2022-2028)

    • 8.6 India Rivastigmine Oral Consumption Forecast (2022-2028)

    • 8.7 South Korea Rivastigmine Oral Consumption Forecast (2022-2028)

    9 Global Rivastigmine Oral Market Outlook by Types and Applications to 2022

    • 9.1 Global Rivastigmine Oral Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 15 mg Capsules Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 3 mg Capsules Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global 45 mg Capsules Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global 6 mg Capsules Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global 2mg/ml Oral solution Consumption and Growth Rate (2017-2022)

    • 9.2 Global Rivastigmine Oral Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Alzheimer's disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Parkinson's Consumption and Growth Rate (2017-2022)

    10 Global Rivastigmine Oral Market Outlook by Types and Applications to 2028

    • 10.1 Global Rivastigmine Oral Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global 15 mg Capsules Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global 3 mg Capsules Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global 45 mg Capsules Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global 6 mg Capsules Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global 2mg/ml Oral solution Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Rivastigmine Oral Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Alzheimer's disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Parkinson's Consumption Forecast and Growth Rate (2022-2028)

    11 Global Rivastigmine Oral Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Rivastigmine Oral Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Rivastigmine Oral Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Rivastigmine Oral Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Rivastigmine Oral Market Competitive Analysis

    • 14.1 APOTEX

      • 14.1.1 APOTEX Company Details

      • 14.1.2 APOTEX Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 APOTEX Rivastigmine Oral Product and Service

    • 14.2 Novartis

      • 14.2.1 Novartis Company Details

      • 14.2.2 Novartis Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis Rivastigmine Oral Product and Service

    • 14.3 Teva

      • 14.3.1 Teva Company Details

      • 14.3.2 Teva Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Teva Rivastigmine Oral Product and Service

    • 14.4 Alembic Pharmaceuticals

      • 14.4.1 Alembic Pharmaceuticals Company Details

      • 14.4.2 Alembic Pharmaceuticals Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Alembic Pharmaceuticals Rivastigmine Oral Product and Service

    • 14.5 Cadila Pharmaceuticals

      • 14.5.1 Cadila Pharmaceuticals Company Details

      • 14.5.2 Cadila Pharmaceuticals Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Cadila Pharmaceuticals Rivastigmine Oral Product and Service

    • 14.6 Ajanta Pharma

      • 14.6.1 Ajanta Pharma Company Details

      • 14.6.2 Ajanta Pharma Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Ajanta Pharma Rivastigmine Oral Product and Service

    • 14.7 Dr Reddy's Laboratories

      • 14.7.1 Dr Reddy's Laboratories Company Details

      • 14.7.2 Dr Reddy's Laboratories Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Dr Reddy's Laboratories Rivastigmine Oral Product and Service

    • 14.8 Orchid Healthcare

      • 14.8.1 Orchid Healthcare Company Details

      • 14.8.2 Orchid Healthcare Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Orchid Healthcare Rivastigmine Oral Product and Service

    • 14.9 Aurobindo Pharma

      • 14.9.1 Aurobindo Pharma Company Details

      • 14.9.2 Aurobindo Pharma Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Aurobindo Pharma Rivastigmine Oral Product and Service

    • 14.10 Mylan Pharmaceuticals

      • 14.10.1 Mylan Pharmaceuticals Company Details

      • 14.10.2 Mylan Pharmaceuticals Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Mylan Pharmaceuticals Rivastigmine Oral Product and Service

    • 14.11 Sun Pharmaceutical

      • 14.11.1 Sun Pharmaceutical Company Details

      • 14.11.2 Sun Pharmaceutical Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Sun Pharmaceutical Rivastigmine Oral Product and Service

    • 14.12 MACLEODS

      • 14.12.1 MACLEODS Company Details

      • 14.12.2 MACLEODS Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 MACLEODS Rivastigmine Oral Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Rivastigmine Oral

    • Figure Rivastigmine Oral Picture

    • Table Global Rivastigmine Oral Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Rivastigmine Oral Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Rivastigmine Oral Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Rivastigmine Oral Consumption by Country (2017-2022)

    • Figure United States Rivastigmine Oral Consumption and Growth Rate (2017-2022)

    • Table Europe Rivastigmine Oral Consumption and Growth Rate (2017-2022)

    • Figure China Rivastigmine Oral Consumption and Growth Rate (2017-2022)

    • Figure Japan Rivastigmine Oral Consumption and Growth Rate (2017-2022)

    • Figure India Rivastigmine Oral Consumption and Growth Rate (2017-2022)

    • Figure South Korea Rivastigmine Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Rivastigmine Oral Consumption Forecast by Country (2022-2028)

    • Figure United States Rivastigmine Oral Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Rivastigmine Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Rivastigmine Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Rivastigmine Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Rivastigmine Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Rivastigmine Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 15 mg Capsules Consumption and Growth Rate (2017-2022)

    • Figure Global 3 mg Capsules Consumption and Growth Rate (2017-2022)

    • Figure Global 45 mg Capsules Consumption and Growth Rate (2017-2022)

    • Figure Global 6 mg Capsules Consumption and Growth Rate (2017-2022)

    • Figure Global 2mg/ml Oral solution Consumption and Growth Rate (2017-2022)

    • Figure Global Alzheimer's disease Consumption and Growth Rate (2017-2022)

    • Figure Global Parkinson's Consumption and Growth Rate (2017-2022)

    • Figure Global 15 mg Capsules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 3 mg Capsules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 45 mg Capsules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 6 mg Capsules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 2mg/ml Oral solution Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alzheimer's disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Parkinson's Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Rivastigmine Oral Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Rivastigmine Oral Export by Region (Top 5 Countries) (2017-2028)

    • Table APOTEX (Foundation Year, Company Profile and etc.)

    • Table APOTEX Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

    • Table APOTEX Rivastigmine Oral Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Rivastigmine Oral Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Rivastigmine Oral Product and Service

    • Table Alembic Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Alembic Pharmaceuticals Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alembic Pharmaceuticals Rivastigmine Oral Product and Service

    • Table Cadila Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Cadila Pharmaceuticals Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cadila Pharmaceuticals Rivastigmine Oral Product and Service

    • Table Ajanta Pharma (Foundation Year, Company Profile and etc.)

    • Table Ajanta Pharma Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ajanta Pharma Rivastigmine Oral Product and Service

    • Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)

    • Table Dr Reddy's Laboratories Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy's Laboratories Rivastigmine Oral Product and Service

    • Table Orchid Healthcare (Foundation Year, Company Profile and etc.)

    • Table Orchid Healthcare Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orchid Healthcare Rivastigmine Oral Product and Service

    • Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)

    • Table Aurobindo Pharma Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurobindo Pharma Rivastigmine Oral Product and Service

    • Table Mylan Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Mylan Pharmaceuticals Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Pharmaceuticals Rivastigmine Oral Product and Service

    • Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceutical Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Rivastigmine Oral Product and Service

    • Table MACLEODS (Foundation Year, Company Profile and etc.)

    • Table MACLEODS Rivastigmine Oral Sales, Price, Value and Gross Profit (2017-2022)

    • Table MACLEODS Rivastigmine Oral Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US